Back

Comparative characteristics of patients with cardiac amyloidosis with and without monoclonal gammopathy in the TTRACK study population

20 May 2025 (09:00 - 09:45)
Organised by: Logo
Congress Presentation Part of: Frailty and biomarkers in heart failure Epidemiology, Prognosis, Outcome HFA Premium Access Heart Failure 2025 Heart Failure Association (HFA)

About the speaker

Photo
Professor Ruxandra Oana Jurcut

Institute of Cardiovascular Diseases Prof. C.C. Iliescu, Bucharest (Romania)

4 More presentations in this session

Presentation thumbnail
Survival analysis of nonagenarian patients in a specific heart failure unit
Mrs S. Gonzalez Sosa (Palmas de Gran Canaria, Las, ES)
Abstract Slides Video
Presentation thumbnail
Serially measured blood biomarkers collected in the context of usual care predict clinical outcome in a real-world heart failure population
Mr T. Kok (Rotterdam, NL)
Abstract Slides Video
Presentation thumbnail
Characteristics of heart failure patients treated in primary care - a 20-year perspective of real-world data.
Doctor A. Drohomirecka (Warsaw, PL)
Abstract Slides Video
Presentation thumbnail
Association of charlson comorbidity index with clinical characteristics and outcomes in heart failure across the EF spectrum
Doctor N. Farooqui (Rochester, US)
Abstract Slides Video

Access the full session

Session thumbnail
Frailty and biomarkers in heart failure

The Event

Event poster

Heart Failure 2025

20 May 2025 09:00 CET
You may be interested in
thumbnail
Congress Presentation
Comparative characteristics of patients with and without transthyretin amyloid cardiomyopathy in the TTRACK study population
thumbnail
Congress Presentation
Development of TTRACK study diagnostic scores to identify elevated risk of transthyretin amyloid cardiomyopathy in older patients with unexplained hypertrophic cardiomyopathy
thumbnail
Congress Presentation
Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: clinical, cardiac imaging, and electrocardiographic findings from the TTRACK study

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources